Trials / Sponsors / GeoVax, Inc.
GeoVax, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia | Phase 2 | 2021-09-27 |
| Completed | A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection COVID-19 Infection | Phase 1 / Phase 2 | 2020-11-19 |
| Completed | Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/N Recurrent Head and Neck Cancer | Phase 1 / Phase 2 | 2019-02-11 |
| Completed | A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART HIV-1 Infection | Phase 1 | 2010-06-01 |